-
1
-
-
15844431142
-
Daptomycin: A lipopeptide antibiotic for the treatment of serious Gram-positive infections
-
J.N. Steenbergen, J. Alder, G.M. Thorne, and F.P. Tally Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections J Antimicrob Chemother 55 2005 283 288
-
(2005)
J Antimicrob Chemother
, vol.55
, pp. 283-288
-
-
Steenbergen, J.N.1
Alder, J.2
Thorne, G.M.3
Tally, F.P.4
-
2
-
-
26944497198
-
Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus
-
M.K. Hayden, K. Rezai, R.A. Hayes, K. Lolans, J.P. Quinn, and R.A. Weinstein Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus J Clin Microbiol 43 2005 5285 5287
-
(2005)
J Clin Microbiol
, vol.43
, pp. 5285-5287
-
-
Hayden, M.K.1
Rezai, K.2
Hayes, R.A.3
Lolans, K.4
Quinn, J.P.5
Weinstein, R.A.6
-
3
-
-
40749132171
-
Bacteremia and infective endocarditis caused by a non-daptomycin- susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan
-
Y.T. Huang, C.H. Hsiao, C.H. Liao, C.W. Lee, and P.R. Hsueh Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan J Clin Microbiol 46 2008 1132 1136
-
(2008)
J Clin Microbiol
, vol.46
, pp. 1132-1136
-
-
Huang, Y.T.1
Hsiao, C.H.2
Liao, C.H.3
Lee, C.W.4
Hsueh, P.R.5
-
4
-
-
84872858655
-
Mechanisms of daptomycin resistance in Staphylococcus aureus: Role of the cell membrane and cell wall
-
A.S. Bayer, T. Schneider, and H.G. Sahl Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall Ann N Y Acad Sci 1277 2013 139 158
-
(2013)
Ann N y Acad Sci
, vol.1277
, pp. 139-158
-
-
Bayer, A.S.1
Schneider, T.2
Sahl, H.G.3
-
5
-
-
0037378761
-
Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects
-
B.H. Dvorchik, D. Brazier, M.F. DeBruin, and R.D. Arbeit Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects Antimicrob Agents Chemother 47 2003 1318 1323
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 1318-1323
-
-
Dvorchik, B.H.1
Brazier, D.2
Debruin, M.F.3
Arbeit, R.D.4
-
6
-
-
33644655658
-
Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
-
L. Cui, E. Tominaga, H.M. Neoh, and K. Hiramatsu Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus Antimicrob Agents Chemother 50 2006 1079 1082
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 1079-1082
-
-
Cui, L.1
Tominaga, E.2
Neoh, H.M.3
Hiramatsu, K.4
-
7
-
-
33645760459
-
Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin
-
G. Sakoulas, J. Alder, C. Thauvin-Eliopoulos, R.C. Moellering Jr., and G.M. Eliopoulos Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin Antimicrob Agents Chemother 50 2006 1581 1585
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 1581-1585
-
-
Sakoulas, G.1
Alder, J.2
Thauvin-Eliopoulos, C.3
Moellering, Jr.R.C.4
Eliopoulos, G.M.5
-
8
-
-
15744365907
-
Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia
-
A. Mangili, I. Bica, D.R. Snydman, and D.H. Hamer Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia Clin Infect Dis 40 2005 1058 1060
-
(2005)
Clin Infect Dis
, vol.40
, pp. 1058-1060
-
-
Mangili, A.1
Bica, I.2
Snydman, D.R.3
Hamer, D.H.4
-
9
-
-
80051824106
-
In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates
-
N.N. Mishra, J. McKinnell, M.R. Yeaman, M. Rubio, C.C. Nast, and L. Chen In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates Antimicrob Agents Chemother 55 2011 4012 4018
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 4012-4018
-
-
Mishra, N.N.1
McKinnell, J.2
Yeaman, M.R.3
Rubio, M.4
Nast, C.C.5
Chen, L.6
-
10
-
-
84890798321
-
-
Committee On Antimicrobial Susceptibility Testing (eucast) E. EUCAST [accessed 30.09.13]
-
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1, valid from 2013-02-11 2013 EUCAST http://www.eucast.org/fileadmin/src/media/ PDFs/EUCAST-files/Breakpoint-tables/Breakpoint-table-v-3.1.pdf [accessed 30.09.13]
-
(2013)
Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 3.1, Valid from 2013-02-11
-
-
-
13
-
-
77955352834
-
Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: Evidence for multiple resistance mechanisms
-
S.J. Yang, C.C. Nast, N.N. Mishra, M.R. Yeaman, P.D. Fey, and A.S. Bayer Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms Antimicrob Agents Chemother 54 2010 3079 3085
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 3079-3085
-
-
Yang, S.J.1
Nast, C.C.2
Mishra, N.N.3
Yeaman, M.R.4
Fey, P.D.5
Bayer, A.S.6
-
14
-
-
67049086960
-
Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus
-
N.N. Mishra, S.J. Yang, A. Sawa, A. Rubio, C.C. Nast, and M.R. Yeaman Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 53 2009 2312 2318
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 2312-2318
-
-
Mishra, N.N.1
Yang, S.J.2
Sawa, A.3
Rubio, A.4
Nast, C.C.5
Yeaman, M.R.6
-
15
-
-
71949109053
-
Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus
-
S.J. Yang, B.N. Kreiswirth, G. Sakoulas, M.R. Yeaman, Y.Q. Xiong, and A. Sawa Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus J Infect Dis 200 2009 1916 1920
-
(2009)
J Infect Dis
, vol.200
, pp. 1916-1920
-
-
Yang, S.J.1
Kreiswirth, B.N.2
Sakoulas, G.3
Yeaman, M.R.4
Xiong, Y.Q.5
Sawa, A.6
-
16
-
-
84855565269
-
Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains
-
V. Cafiso, T. Bertuccio, D. Spina, S. Purrello, F. Campanile, and C. Di Pietro Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains PLoS One 7 2012 e29573
-
(2012)
PLoS One
, vol.7
, pp. 29573
-
-
Cafiso, V.1
Bertuccio, T.2
Spina, D.3
Purrello, S.4
Campanile, F.5
Di Pietro, C.6
-
17
-
-
74249096623
-
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: Resistance mechanisms, laboratory detection, and clinical implications
-
B.P. Howden, J.K. Davies, P.D. Johnson, T.P. Stinear, and M.L. Grayson Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications Clin Microbiol Rev 23 2010 99 139
-
(2010)
Clin Microbiol Rev
, vol.23
, pp. 99-139
-
-
Howden, B.P.1
Davies, J.K.2
Johnson, P.D.3
Stinear, T.P.4
Grayson, M.L.5
-
18
-
-
84879047022
-
Increased cell wall teichoic acid production and d-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates
-
U. Bertsche, S.J. Yang, D. Kuehner, S. Wanner, N.N. Mishra, and T. Roth Increased cell wall teichoic acid production and d-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates PLoS One 8 2013 e67398
-
(2013)
PLoS One
, vol.8
, pp. 67398
-
-
Bertsche, U.1
Yang, S.J.2
Kuehner, D.3
Wanner, S.4
Mishra, N.N.5
Roth, T.6
-
19
-
-
0015295769
-
Biosynthesis of cardiolipin from phosphatidylglycerol in Staphylococcus aureus
-
S.A. Short, and D.C. White Biosynthesis of cardiolipin from phosphatidylglycerol in Staphylococcus aureus J Bacteriol 109 1972 820 826
-
(1972)
J Bacteriol
, vol.109
, pp. 820-826
-
-
Short, S.A.1
White, D.C.2
-
20
-
-
84855416641
-
Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus
-
A.Y. Peleg, S. Miyakis, D.V. Ward, A.M. Earl, A. Rubio, and D.R. Cameron Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus PLoS One 7 2012 e28316
-
(2012)
PLoS One
, vol.7
, pp. 28316
-
-
Peleg, A.Y.1
Miyakis, S.2
Ward, D.V.3
Earl, A.M.4
Rubio, A.5
Cameron, D.R.6
-
22
-
-
77957671675
-
Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates
-
F. Campanile, S. Borbone, M. Perez, D. Bongiorno, V. Cafiso, and T. Bertuccio Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates Int J Antimicrob Agents 36 2010 415 419
-
(2010)
Int J Antimicrob Agents
, vol.36
, pp. 415-419
-
-
Campanile, F.1
Borbone, S.2
Perez, M.3
Bongiorno, D.4
Cafiso, V.5
Bertuccio, T.6
-
23
-
-
0035044562
-
A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital
-
Erratum in: J Antimicrob Chemother 2001; 48: 161.
-
M. Wootton, R.A. Howe, R. Hillman, T.R. Walsh, P.M. Bennett, and A.P. MacGowan A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital J Antimicrob Chemother 47 2001 399 403 Erratum in: J Antimicrob Chemother 2001; 48: 161.
-
(2001)
J Antimicrob Chemother
, vol.47
, pp. 399-403
-
-
Wootton, M.1
Howe, R.A.2
Hillman, R.3
Walsh, T.R.4
Bennett, P.M.5
Macgowan, A.P.6
-
24
-
-
84859996613
-
A novel δ-hemolysis screening method to detect heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-intermediate S. Aureus
-
V. Cafiso, T. Bertuccio, D. Spina, S. Purrello, G. Blandino, and S. Stefani A novel δ-hemolysis screening method to detect heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-intermediate S. aureus J Clin Microbiol 50 2012 1742 1744
-
(2012)
J Clin Microbiol
, vol.50
, pp. 1742-1744
-
-
Cafiso, V.1
Bertuccio, T.2
Spina, D.3
Purrello, S.4
Blandino, G.5
Stefani, S.6
-
25
-
-
0036581160
-
Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR
-
M.W. Pfaffl, G.W. Horgan, and L. Dempfle Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR Nucleic Acids Res 30 2002 e36
-
(2002)
Nucleic Acids Res
, vol.30
, pp. 36
-
-
Pfaffl, M.W.1
Horgan, G.W.2
Dempfle, L.3
-
26
-
-
64549161964
-
Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy
-
F.C. Tenover, S.W. Sinner, R.E. Segal, V. Huang, S.S. Alexandre, and J.E. MacGowan Jr. Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy Int J Antimicrob Agents 33 2009 564 568
-
(2009)
Int J Antimicrob Agents
, vol.33
, pp. 564-568
-
-
Tenover, F.C.1
Sinner, S.W.2
Segal, R.E.3
Huang, V.4
Alexandre, S.S.5
Macgowan, Jr.J.E.6
-
27
-
-
0029111720
-
Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis
-
W. Graninger, C. Wenisch, E. Wiesinger, M. Menschik, J. Karimi, and E. Presterl Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis Eur J Clin Microbiol Infect Dis 14 1995 643 647
-
(1995)
Eur J Clin Microbiol Infect Dis
, vol.14
, pp. 643-647
-
-
Graninger, W.1
Wenisch, C.2
Wiesinger, E.3
Menschik, M.4
Karimi, J.5
Presterl, E.6
-
28
-
-
0037443852
-
Staphylococcus aureus accessory gene regulator (agr) group II: Is there a relationship to the development of intermediate-level glycopeptide resistance?
-
G. Sakoulas, G.M. Eliopoulos, R.C. Moellering Jr., R.P. Novick, L. Venkataraman, and C. Wennersten Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? J Infect Dis 187 2003 929 938
-
(2003)
J Infect Dis
, vol.187
, pp. 929-938
-
-
Sakoulas, G.1
Eliopoulos, G.M.2
Moellering, Jr.R.C.3
Novick, R.P.4
Venkataraman, L.5
Wennersten, C.6
-
29
-
-
34548579184
-
Agr-Genotyping and transcriptional analysis of biofilm-producing Staphylococcus aureus
-
V. Cafiso, T. Bertuccio, M. Santagati, V. Demelio, D. Spina, and G. Nicoletti agr-Genotyping and transcriptional analysis of biofilm-producing Staphylococcus aureus FEMS Immunol Med Microbiol 51 2007 220 227
-
(2007)
FEMS Immunol Med Microbiol
, vol.51
, pp. 220-227
-
-
Cafiso, V.1
Bertuccio, T.2
Santagati, M.3
Demelio, V.4
Spina, D.5
Nicoletti, G.6
-
30
-
-
67049086887
-
Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains
-
S.J. Yang, Y.Q. Xiong, P.M. Dunman, J. Schrenzel, P. François, and A. Peschel Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains Antimicrob Agents Chemother 53 2009 2636 2637
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 2636-2637
-
-
Yang, S.J.1
Xiong, Y.Q.2
Dunman, P.M.3
Schrenzel, J.4
François, P.5
Peschel, A.6
-
31
-
-
84872836267
-
Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus
-
N.N. Mishra, and A.S. Bayer Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 57 2013 1082 1085
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 1082-1085
-
-
Mishra, N.N.1
Bayer, A.S.2
|